CombiMatrix was acquired by Invitae in November 2017. Invitae Corporation (NYSE:NVTA) is one of the fastest growing genetic information companies in the United States, dedicated to bringing comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. Invitae provides comprehensive genetic information for every stage of life, from preconception through adult diagnostics. For more information, visit our website at invitae.com.
CombiMatrix is a clinical diagnostic laboratory specializing in cytogenomic testing for preimplantation genetic testing (PGS and PGD), prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. As a full-scale cytogenetic and cytogenomic laboratory, we offer single nucleotide polymorphism (SNP) chromosomal microarray analysis, next generation sequencing (NGS), standard and customized FISH, and high resolution karyotyping to help clinicians better care for their patients.
We pride ourselves on the clinical and molecular diagnostic expertise of our medical team, and the technical expertise of our scientists and laboratory technicians. We remain committed to providing you with the best care possible with the goal of aggregating the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower prices.
WHAT SETS US APART
We understand that there is more to being a clinical laboratory than simply offering impeccable customer service, and accurate, timely results. We believe that it is our obligation to provide in- depth clinical support to our clients so that they can spend more time doing what they do best; caring for patients. We employ the latest in technological advancements to provide in-depth answers to complex health questions in prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders.
Experience matters when it comes to diagnostic testing. We specialize in microarray analysis, and have been serving the clinical diagnostic needs of the medical community since 2005. Our goal is to provide you with results that impact clinical care. That is why our company has been active part of the International Collaboration for Clinical Genomics (formerly the International Standardization for Cytogenomic Arrays Consortium) since its inception, and supports the development of international databases to help gather and curate cytogenomic data.
We maintain a proprietary database of genomic variants which is used in tandem with nationally-available databases to help maximize the clinical utility of our results. Every result is carefully reviewed by our Laboratory Medical Directors and team of genetic counselors, and result interpretations are supported by extensive literature searches, database queries, and the shared clinical expertise of our medical team. For more information, visit our website at invitae.com.